These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14963062

  • 1. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH, Houck H.
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [Abstract] [Full Text] [Related]

  • 2. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH, Houck HJ.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [Abstract] [Full Text] [Related]

  • 3. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
    Rand KH, Houck HJ, Silverman JA.
    J Antimicrob Chemother; 2007 May; 59(5):1017-20. PubMed ID: 17369277
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 5. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G, Ashcraft D, Patel N.
    Antimicrob Agents Chemother; 2005 Dec 18; 49(12):5166-8. PubMed ID: 16304195
    [Abstract] [Full Text] [Related]

  • 6. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM, Giddey M, Vouillamoz J, Moreillon P.
    Int J Antimicrob Agents; 2010 May 18; 35(5):451-6. PubMed ID: 20185277
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 18; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 9. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J.
    J Antimicrob Chemother; 2007 Jun 18; 59(6):1185-9. PubMed ID: 17412725
    [Abstract] [Full Text] [Related]

  • 10. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA, McCoy D, Desai S, Nyirenda T, Bicking K.
    J Antimicrob Chemother; 2011 Sep 18; 66(9):2112-8. PubMed ID: 21697178
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ.
    J Antimicrob Chemother; 2014 Aug 18; 69(8):2148-54. PubMed ID: 24777900
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
    Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, Sakoulas G, Nonejuie P, Pogliano J, Nizet V, Humphries R.
    Antimicrob Agents Chemother; 2015 Jul 18; 59(7):4279-88. PubMed ID: 25963982
    [Abstract] [Full Text] [Related]

  • 13. [Detection of antibiotic resistance in Enterococcus sp. Comparison of GPS-TA (BioMérieux-Vitek), Uniscept MIC-3 (bioMérieux-Vitek) and conventional methods].
    Alamo I, González A.
    Enferm Infecc Microbiol Clin; 1995 Nov 18; 13(9):516-21. PubMed ID: 8519833
    [Abstract] [Full Text] [Related]

  • 14. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
    Duez JM, Péchinot A, Siébor E, Cordin X, Kazmierczak A.
    Pathol Biol (Paris); 1989 Apr 18; 37(4):263-8. PubMed ID: 2543946
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
    Chang PC, Li HY, Tang HJ, Liu JW, Wang JJ, Chuang YC.
    J Microbiol Immunol Infect; 2007 Feb 18; 40(1):56-61. PubMed ID: 17332908
    [Abstract] [Full Text] [Related]

  • 16. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH, Crawford SA.
    J Clin Microbiol; 2006 Jun 18; 44(6):2126-9. PubMed ID: 16757608
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
    Hellmark B, Unemo M, Nilsdotter-Augustinsson A, Söderquist B.
    Clin Microbiol Infect; 2009 Mar 18; 15(3):238-44. PubMed ID: 19196261
    [Abstract] [Full Text] [Related]

  • 18. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
    Steenbergen JN, Mohr JF, Thorne GM.
    J Antimicrob Chemother; 2009 Dec 18; 64(6):1130-8. PubMed ID: 19825818
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Clin Microbiol Infect; 2006 Sep 18; 12(9):844-52. PubMed ID: 16882289
    [Abstract] [Full Text] [Related]

  • 20. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G.
    J Antimicrob Chemother; 2007 Jun 18; 59(6):1190-3. PubMed ID: 17434881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.